Contents

Current Medicinal Chemistry - Anti-Cancer Agents, Volume 3 - Number 1

Preface

, 3(1): i

Doriano Fabbro


DOI: 10.2174/1568011033353498




Chemical and Biological Profile of Dual Cdk1 and Cdk2 Inhibitors

, 3(1): 1 - 14

Stephan Ruetz, Doriano Fabbro, Juerg Zimmermann, Thomas Meyer and Nathanael Gray


DOI: 10.2174/1568011033353605




X-Ray Crystallographic Studies of CDK2, a Basis for Cyclin-Dependent Kinase Inhibitor Design in Anti-Cancer Drug Research

, 3(1): 15 - 23

Pascal Furet


DOI: 10.2174/1568011033353515




Structure-Based Design of Novel Anti-Cancer Agents TargetingAurora Kinases

, 3(1): 25 - 34

Daruka Mahadevan, David J. Bearss and Hariprasad Vankayalapati


DOI: 10.2174/1568011033353524




Potentiation of DNA-Damage-Induced Cytotoxicity by G2Checkpoint Abrogators

, 3(1): 35 - 46

A. Tenzer and M. Pruschy


DOI: 10.2174/1568011033353533




Cyclin-Dependent Kinase Modulators Studied at the NCI: Pre-Clinical and Clinical Studies

, 3(1): 47 - 56

Edward A. Sausville


DOI: 10.2174/1568011033353560




Peptidomimetic Design of CDK Inhibitors Targeting theRecruitment Site of the Cyclin Subunit

, 3(1): 57 - 69

David P. Lane and Peter M. Fischer


DOI: 10.2174/1568011033353506




Author Index To Volume 2

, 3(1): 71 - 72

Bentham Science Publishers


DOI: 10.2174/1568011033353542




Subject Index To Volume 2

, 3(1): 73 - 76

Bentham Science Publishers


DOI: 10.2174/1568011033353588




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science